The success of a clinical study depends on the CRO’s or sponsor’s ability to bring together people, processes, and technology in a coordinated effort to improve patient outcomes, one case at a time.
To help you understand why personalized therapies require a personalized supply chain, we’ve published Tomorrow’s Medicine: Curing One Patient at a Time – an e-book highlighting the logistics challenges of cell and gene therapies.
Top 10 questions and answers to consider when conducting direct-to-patient clinical trials
Japan is the world's second largest single-country pharmaceutical market, accounting for approximately 10 per cent of global drug sales, and is expanding very quickly.
Scandinavia and Nordic progression with clinical trials